Mary Weeks
Family · West Columbia, SCNPI 1689299406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $279 and has fallen 62.3% since, to $105 in 2025.
Across 38 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$88
- AstraZeneca$74
- Astellas Pharma US Inc$69
- Exeltis, USA Inc.$66
- Exact Sciences$64
- Organon$46
- plus $284 from 13 others
What the payments were for
- Food & beverage$690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $88 |
| AstraZeneca | 6 | $74 |
| Astellas Pharma US Inc | 3 | $69 |
| Exeltis, USA Inc. | 4 | $66 |
| Exact Sciences | 3 | $64 |
| Organon | 4 | $46 |
| Amarin Pharma, Inc. | 3 | $45 |
| Novo Nordisk | 2 | $41 |
| Merck | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Edwards Lifesciences | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Pfizer | 1 | $15 |
| AbbVie | 1 | $12 |
| Hikma Pharmaceuticals USA | 1 | $11 |
| Eyevance Pharmaceuticals LLC | 1 | $11 |
How this compares
$690 in reported general payments places this provider in the 60th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 14 | $1,819 |
| Estradiol | 13 | $360 |
Paid to pharmacies, not to this prescriber.
Other family in West Columbia
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.